Technique
Supplier
Species
Label
Iso Type
Host
Tissue
RXRA antibody
RXRA antibody size: 1 vial 521
Supplier
GENWAYS
Price
521
Size
1 vial
Contact us
Ask Component cell markers and DNA bp. markers are genetic markerser genes
or DNA sequenceswith
selection audit
| Storage temperature | store cold |
| Expiry date | 1 y |
| Category | ELISAs, recombinant proteins, vectors and reagents for laboratory use, research antibodies |
| French translation | anticorps |
| Gene target | RXRA |
| Short name | RXRA antibody |
| Alternative name | alpha (Antibody to), retinoid X receptor |
| Alternative technique | antibodies |
| Alternative to gene target | BT, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0006766 and vitamin metabolic process and biological process this GO :0007507 and heart development and biological process this GO :0007566 and embryo implantation and biological process this GO :0008134 and transcription factor binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008270 and zinc ion binding and molecular function this GO :0010467 and gene expression and biological process this GO :0019048 and modulation by virus of host morphology or physiology and biological process this GO :0019899 and enzyme binding and molecular function this GO :0031490 and chromatin DNA binding and molecular function this GO :0032526 and response to retinoic acid and biological process this GO :0035357 and peroxisome proliferator activated receptor signaling pathway and biological process this GO :0042809 and vitamin D receptor binding and molecular function this GO :0043010 and camera-type eye development and biological process this GO :0043401 and steroid hormone mediated signaling pathway and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0044212 and transcription regulatory region DNA binding and molecular function this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0044323 and retinoic acid-responsive element binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048384 and retinoic acid receptor signaling pathway and biological process this GO :0051289 and protein homotetramerization and biological process this GO :0055010 and ventricular cardiac muscle tissue morphogenesis and biological process this GO :0055012 and ventricular cardiac muscle cell differentiation and biological process this GO :0060038 and cardiac muscle cell proliferation and biological process this GO :0060528 and secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development and biological process this GO :0060687 and regulation of branching involved in prostate gland morphogenesis and biological process this GO :0070644 and vitamin D response element binding and molecular function, NR2B1, RXRA and IDBG-91747 and ENSG00000186350 and 6256, Rxra and IDBG-151388 and ENSMUSG00000015846 and 20181, alpha, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000790 and nuclear chromatin and cellular component this GO :0000977 and RNA polymerase II regulatory region sequence-specific DNA binding and molecular function this GO :0001701 and in utero embryonic development and biological process this GO :0001890 and placenta development and biological process this GO :0001893 and maternal placenta development and biological process this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003707 and steroid hormone receptor activity and molecular function this GO :0003708 and retinoic acid receptor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0004879 and ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity and molecular function this GO :0004886 and 9-cis retinoic acid receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0006351 and transcription, this GO :0000977: RNA polymerase II regulatory region sequence-specific DNA binding, this GO :0000977: RNA polymerase II regulatory region sequence-specific DNA binding and also this GO :0003677: DNA binding and also this GO :0003700: sequence-specific DNA binding transcription factor activity and also this GO :0003707: steroid hormone receptor activity and also this GO :0003708: retinoic acid receptor activity and also this GO :0003713: transcription coactivator activity and also this GO :0004879: ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity and also this GO :0004886: 9-cis retinoic acid receptor activity and also this GO :0005515: protein binding and also this GO :0008134: transcription factor binding and also this GO :0008270: zinc ion binding and also this GO :0019899: enzyme binding and also this GO :0031490: chromatin DNA binding and also this GO :0042809: vitamin D receptor binding and also this GO :0043565: sequence-specific DNA binding and also this GO :0044212: transcription regulatory region DNA binding and also this GO :0044323: retinoic acid-responsive element binding and also this GO :0046982: protein heterodimerization activity and also this GO :0070644: vitamin D response element binding, this GO :0003677: DNA binding, this GO :0003700: sequence-specific DNA binding transcription factor activity, this GO :0003707: steroid hormone receptor activity, this GO :0003708: retinoic acid receptor activity, this GO :0003713: transcription coactivator activity, this GO :0004879: ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity, this GO :0004886: 9-cis retinoic acid receptor activity, this GO :0005515: protein binding, this GO :0008134: transcription factor binding, this GO :0008270: zinc ion binding, this GO :0019899: enzyme binding, this GO :0031490: chromatin DNA binding, this GO :0042809: vitamin D receptor binding, this GO :0043565: sequence-specific DNA binding, this GO :0044212: transcription regulatory region DNA binding, this GO :0044323: retinoic acid-responsive element binding, this GO :0046982: protein heterodimerization activity, this GO :0070644: vitamin D response element binding, vitamin D response element binding, 78456 and IDBG-641227 and ENSBTAG00000017851 and 507554, retinoid X receptor |
| Identity | 10477 |
| Gene | RXRA |
| Long gene name | retinoid X receptor alpha |
| Synonyms gene name | alpha , retinoid X receptor |
| Synonyms | NR2B1 |
| Synonyms name | nuclear receptor subfamily 2 group B member 1 |
| Locus | 9q34, 2 |
| Discovery year | 1991-11-14 |
| GenBank acession | X52773 |
| Entrez gene record | 6256 |
| Pubmed identfication | 2159111 |
| RefSeq identity | NM_002957 |
| Classification | Nuclear hormone receptors |
| Havana BLAST/BLAT | OTTHUMG00000020887 |